Transcranial Magnetic Stimulation as a Treatment for Postpartum Obsessive Compulsive Disorder (NCT07571187) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Transcranial Magnetic Stimulation as a Treatment for Postpartum Obsessive Compulsive Disorder
15 participantsStarted 2026-04
Plain-language summary
The goal of this clinical trial is to learn if accelerated transcranial magnetic stimulation (TMS) is a feasible treatment for obsessive compulsive disorder that worsens or starts within 12 months of childbirth. The main questions it aims to answer are:
Is TMS a tolerable and acceptable treatment for postpartum women with OCD?
Does TMS improve OCD symptoms in postpartum women?
Does TMS change connectivity between areas of the brain involved in OCD?
Participants will:
1. Receive 50 sessions of a type of TMS called continuous theta burst stimulation (cTBS) over the course of two weeks.
2. Complete clinical assessments before and after TMS, as well as at 1 and 3 months post-treatment
3. Undergo functional magnetic resonance imaging (fMRI) of the brain before and after TMS
Who can participate
Age range18 Years – 45 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Age 18-45
✓. Diagnosis of OCD defined by DSM-V criteria with problematic symptoms in the 12 months following childbirth
✓. YBOCS ≥16
✓. Either currently taking OCD medications at a stable dose for 8 weeks or unmedicated
✓. Concurrent psychotherapy (exposure and response prevention therapy) will be allowed if it was initiated 8 weeks or more before study entry and continues regularly throughout the trial
✓. Ability to read, write and understand English sufficiently well to complete study procedures and provide informed consent.
Exclusion criteria
✕. Past history of a primary psychotic or bipolar disorder
✕. Current acute suicidality or significantly elevated risk of suicide as determined by the investigators
✕. Personal history of moderate traumatic brain injury, epilepsy, or other clinically significant neurological illness except tic disorders
What they're measuring
1
Yale-Brown Obsessive Compulsive Scale (YBOCS)
Timeframe: From enrollment to the end of treatment at two weeks, and from enrollment to 1 and 3 months post-treatment.
✕. A history of pre-eclampsia during the most recent pregnancy if the patient is less than 8 weeks postpartum
✕. Current, moderate to severe alcohol or illicit substance use disorder in the last 3 months, determined by clinical assessment
✕. Women who are currently pregnant. All participants will be asked to use a reasonable birth control method throughout the study period (barrier, oral contraceptives, etc.). We will not administer pregnancy tests.